Fib
Gap Fill- BullishWatching PINS closely here- Sold off after earnings, patiently waiting for a good entry- with a catalyst or an increase in buyer volume relative to seller volume should really pop- will be looking for a breakout broader market conditions permitting. Bullish, just some FIB levels along with some RSI-based supply and demand zones to keep an eye on.
- Big gap to fill on the upside
- Oversold on the RSI
- MACD is seemingly about to cross
PT1- $57.20
PT2- $58.85
PT3- $60.33+ Breakout
SPY- Potential reversal & key levels to watch (Update)SPY looking pretty bearish here (See Previous Charts Below)- Some FIB levels and RSI-based supply and demand zones to keep an eye on-
- Bearish Butterfly Harmonic Pattern Formed
- Decreasing Volume on the 4 hour, daily, and weekly timeframe
- RSI in Overbought Territory
Previous Charts-
BTC to $100k ? Price and target predictionsThis is a quick review on btc price movement and price prediction of what to expect once the all time high is taken out. I personally believe that the ath will be taken out pretty soon as the bearish invalidation has been taken out.
Lets plan for the worse but expect the best.
The King is bacl
AMD short opportunityAMD: Using fib retracement, after an impulsive move a pullback to the 0.5, 0.618, or 0.786 is very likely and healthy in an uptrend.
~ Golden cross happened on the 11th signaling the start of another uptrend.
~ on the 11th AMD did a similar but smaller sized impulse with a pullback to the 0.786. This helps visualize the theory of fib
~ RSI on the hourly has a lot of room to "dump"
Moment of truth - BITCOINHello dear crypto friends!
New all-time high or bear market after all?
No idea. All I know is that all of Twitter is bullish again and influencers are summoning the moon.
Whereas the last remaining bears are looking for explanations.
So what to do?
Keep it simple!
What do we see?
Major Gann resistance for next week, price marked.
And what else is there?
Right, the 0.786 FIB level, which Bitcoin loves for corrections.
I'm not a perma-bear, I'm just saying that these two resistances should be overcome before we dream of a new ATH.
Stick to facts.
Thanks and good trades!
4H $FANTOM #FTM UPDATE4H $FANTOM #FTM UPDATE
$FTMUSDT
Fantom Foundation
FUNDAMENTAL:
1.We're extremely excited to announce that Fantom will work with OJSC Orienbank to trial a CBDC for Tajikistan.
The solution will also use @AndreCronjeTech Iron Bank protocol to enable seamless, low-fee foreign exchange.
2.Announcing a 370 million FTM incentive program for builders!
If you're a protocol team, we'll reward you for sustaining and increasing your TVL on Fantom.
Start building today!
#buildonfantom
NANO Doube Fib Speed Fan plus FractalHello you all!
I hope you are all well.
For the last 4 days, we saw the price of NANO USDT decreasing and this gives me a good fractal to grab hold to.
What I mean is that at the beginning of the last cycle we got a succulent dip which culminated in that nice pump we saw 16 apr `21.
After the dip the price raized and then we saw a dip of about one week before the pump.
Right now we saw a dramatic dip which may indicate that the cycle may repeat, at least at some level of similarity.
Alright. So now we are on the 4 day of the dip, but it seems to me like this movement is a bit more extended than the last one, which means that it could take more than a week for the dip to dip before the potential pump.
These last 4 days of going down gave me a good target for me to place this fractal a little more accurately.
I like how the fractal fits the automatic fib fans by DGT available for free here on trading view.
I hope this was clear enough hahaha
Nice ride you all.
Hex Fib Channel LongHex fib channel using the huge 'glitch' wick as a pivot. This wick acted as a future target despite being extended 10x above the price at the time, proving it's validity in hex charting (imo).
$IPHAKey Words: Innate Pharma S.A. (NASDAQ: IPHA) shares gained 40.9% to close at $8.10 as its partner AstraZeneca Plc (NASDAQ: AZN) presented results from the COAST Phase 2 trial during the European Society for Medical Oncology (ESMO21) Congress 2021. SVB Leerink maintained Innate Pharma with an Outperform and raised the price target from $7 to $9.
Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and peripheral T-cell lymphoma, as well as in Phase II clinical trials to treat refractory sézary syndrome; Monalizumab, an immune checkpoint inhibitor that is in Phase II clinical trial to treat advanced solid tumors comprising colorectal and lung cancer, as well as head and neck cancer; Avdoralimab (IPH5401), a monoclonal antibody blocking C5a binding to C5aR1 that is in Phase II clinicals trials for the treatment of COVID-19, bullous pemphigoid, chronic spontaneous urticaria, and other inflammatory diseases; and IPH5201, a blocking antibody that is in Phase 1 clinical trials targeting the CD39 immunosuppressive pathway. Its products in preclinical trials include IPH5301, an anti-CD73 antibody targeting the immunosuppressive adenosine pathway to promote antitumor immunity; IPH61, NKp46-based NK cell engager for the generation and evaluation of up to two bispecific NK cell engagers; IPH43, an anti-MICA/B antibody drug conjugate; Lumoxiti (moxetumomab pasudotox-tdfk), a tumor antigen targeting solution for the treatment of hairy cell leukemia; Anti-Siglec-9, an antibody program; IPH25, a checkpoint inhibitor; and IPH62, an NKp46-NKCE platform. Innate Pharma S.A. has licensing and collaboration agreements with AstraZeneca, Novo Nordisk A/S, Sanofi, and Orega Biotech; and co-development and license agreement with MedImmune Limited. The company was incorporated in 1999 and is headquartered in Marseille, France.
SHOP descending wedge is as at a lower edgeWhile I'd look for a breakout to the upside to this descending wedge, I think it's equally likely that price will bounce off my purple breakout line and head down for another leg. We'll have to wait and see.
It's also noteworthy to notice we're now trading below the grey resistance area, so that might add an additional ceiling to bounce off.
SPY- Potential reversal & key levels to watchThe SPY closed on Friday finally breaking below the channel that it's been holding for quite some time now, and closed sitting on the 50-day SMA. Every time we've previously touched the top channel line, the SPY has fallen to the bottom channel line and bounced right off (see charts below). However, there is a very clear shift in seller volume starting to outweigh buyers, and RSI taking a steep drop EOD on Friday after hovering in overbought territory for quite some time as well. Just some FIB levels and RSI-based supply and demand zones to keep an eye on- personally bearish here as the markets have been way overextended for a long time now in my opinion. Trade safe, and look for potential long-term entries on fundamentally sound stocks.
Symmetrical Triangle - UpdateBeen a while since I've posted an updated chart on ETH so please see previous charts in description below- Frankly ETH is looking quite nice at the moment holding a big symmetrical triangle on the 4-hour timeframe-
- Reclaimed the 50day EMA and others starting to curl upwards
- Bullish Gartley Harmonic Formed
- Bullish divergence on the RSI
- MACD Cross on the 2-hour & shorter timeframes
- Buyer volume increasing creative to seller
- Just some FIB levels and RSI-based supply and demand zones to keep an eye on- Personally am bullish and holding long term but watching for a breakout from this triangle
Previous Charts-
June 19'
June 5'
May 16'